The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Results of the MONALEESA-2 Study in Advanced Breast Cancer

Gabriel Hortobagyi, MD
Published Online: 7:22 PM, Sat October 8, 2016

Gabriel Hortobagyi, MD, professor of Medicine, University of Texas, MD Anderson Cancer Center, discusses the major findings of the MONALEESA-2 study in advanced breast cancer, during an interview at the 2016 ESMO Congress.

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.